Ce. Hioe et al., NEUTRALIZATION OF HIV-1 PRIMARY ISOLATES BY POLYCLONAL AND MONOCLONALHUMAN-ANTIBODIES, International immunology, 9(9), 1997, pp. 1281-1290
To examine antibody-mediated neutralization of HIV-1 primary isolates
in vitro, we tested sera and plasma from infected individuals against
four clade B primary isolates, These isolates were analyzed further fo
r neutralization by a panel of several human anti-HIV-l mAb in order t
o identify the neutralizing epitopes of these viruses, Each of the HIV
-1(+) serum and plasma specimens tested had neutralizing activities ag
ainst one or more of the four primary isolates, Of the three individua
l sera, one (FDA-2) neutralized all of the four isolates, while the ot
her two sera were effective against only one virus, The pooled plasma
and serum samples reacted broadly with these isolates, Based on the ne
utralizing activities of the mAb panel, each virus isolate exhibited a
distinct pattern of reactivity, suggesting antigenic diversity among
clade B viruses, Neutralizing epitopes were found in the V3 loop and C
D4-binding domain of gp120, as well as near the transmembrane region (
cluster II epitope) of gp41, A mAb directed to the cluster I epitope o
f gp41 near the immunodominant disulfide loop weakly neutralized one p
rimary isolate, None of the mAb in the panel affected one primary isol
ate, US4, although this virus was sensitive to neutralization by some
of the polyclonal antibody specimens, This isolate was also resistant
to neutralization by a cocktail of 10 mAb, most of which individually
inhibited at least one of the other three viruses tested, These result
s suggest that neutralizing activity for this latter virus is present
in certain HIV-1(+) sera/plasma, but is not exhibited by the mAb in th
e panel, Thus, effective neutralizing antibodies against primary isola
tes can be generated by humans upon exposure to HIV-1, but not all of
these antigenic specificities are represented in a large panel of huma
n anti-HIV-1 mAb.